Characterization of an immunopathogenic epitope in rhodopsin that induces experimental autoimmune uveitis

Grazyna Adamus, D. Dugger, A. Arendt, P. A. Hargrave

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Rhodopsin, a membrane protein of red photoreceptor cells, induces experimental autoimmune uveitis in Lewis rats. Synthetic peptides have been used to define pathogenic determinants for rhodopsin. Peptide 230-252 (loop V-VI) was found to contain a major uveitogenic site. Kinetics of the response to the peptide 230-252 was studied. Rats were given a single dose of the synthetic peptide 230-252 (VKEAAAQQQESATTQKAEKEVTR) mixed in complete Freund's adjuvant. Eyes, blood, and splenic lymphocytes were collected at different postinjection times. Histologically confirmed uveitis occurred 14 days after injection, and active inflammation was present for the next 10 days. At first, mild mononuclear cell infiltration with loci of inflammatory cells in the retina was observed. Later, infiltration of photoreceptor cell layer, outer nuclear layer, and inner layer of the retina was characteristic. The cellular responses determined by in vitro lymphocyte proliferation assay indicated strong proliferative activity against immunizing peptide as early as 8 days after injection, with a peak of proliferative activity on days 15- 16. In studies to determine the importance of amino acid residues in induction of experimental autoimmune uveitis, sequence SATTQKAEKEVT (240- 251) has been found to be very immunopotent and to contain the uveitogenic site.

Original languageEnglish (US)
Pages (from-to)44-46
Number of pages3
JournalRegional Immunology
Volume6
Issue number1-2
StatePublished - 1994
Externally publishedYes

Fingerprint

Rhodopsin
Uveitis
Epitopes
Peptides
Photoreceptor Cells
Retina
Lymphocytes
Injections
Freund's Adjuvant
Membrane Proteins
Inflammation
Amino Acids

ASJC Scopus subject areas

  • Immunology

Cite this

Characterization of an immunopathogenic epitope in rhodopsin that induces experimental autoimmune uveitis. / Adamus, Grazyna; Dugger, D.; Arendt, A.; Hargrave, P. A.

In: Regional Immunology, Vol. 6, No. 1-2, 1994, p. 44-46.

Research output: Contribution to journalArticle

@article{b747fb15b6364d54a7ed86fca08e28e2,
title = "Characterization of an immunopathogenic epitope in rhodopsin that induces experimental autoimmune uveitis",
abstract = "Rhodopsin, a membrane protein of red photoreceptor cells, induces experimental autoimmune uveitis in Lewis rats. Synthetic peptides have been used to define pathogenic determinants for rhodopsin. Peptide 230-252 (loop V-VI) was found to contain a major uveitogenic site. Kinetics of the response to the peptide 230-252 was studied. Rats were given a single dose of the synthetic peptide 230-252 (VKEAAAQQQESATTQKAEKEVTR) mixed in complete Freund's adjuvant. Eyes, blood, and splenic lymphocytes were collected at different postinjection times. Histologically confirmed uveitis occurred 14 days after injection, and active inflammation was present for the next 10 days. At first, mild mononuclear cell infiltration with loci of inflammatory cells in the retina was observed. Later, infiltration of photoreceptor cell layer, outer nuclear layer, and inner layer of the retina was characteristic. The cellular responses determined by in vitro lymphocyte proliferation assay indicated strong proliferative activity against immunizing peptide as early as 8 days after injection, with a peak of proliferative activity on days 15- 16. In studies to determine the importance of amino acid residues in induction of experimental autoimmune uveitis, sequence SATTQKAEKEVT (240- 251) has been found to be very immunopotent and to contain the uveitogenic site.",
author = "Grazyna Adamus and D. Dugger and A. Arendt and Hargrave, {P. A.}",
year = "1994",
language = "English (US)",
volume = "6",
pages = "44--46",
journal = "Regional Immunology",
issn = "0896-0623",
number = "1-2",

}

TY - JOUR

T1 - Characterization of an immunopathogenic epitope in rhodopsin that induces experimental autoimmune uveitis

AU - Adamus, Grazyna

AU - Dugger, D.

AU - Arendt, A.

AU - Hargrave, P. A.

PY - 1994

Y1 - 1994

N2 - Rhodopsin, a membrane protein of red photoreceptor cells, induces experimental autoimmune uveitis in Lewis rats. Synthetic peptides have been used to define pathogenic determinants for rhodopsin. Peptide 230-252 (loop V-VI) was found to contain a major uveitogenic site. Kinetics of the response to the peptide 230-252 was studied. Rats were given a single dose of the synthetic peptide 230-252 (VKEAAAQQQESATTQKAEKEVTR) mixed in complete Freund's adjuvant. Eyes, blood, and splenic lymphocytes were collected at different postinjection times. Histologically confirmed uveitis occurred 14 days after injection, and active inflammation was present for the next 10 days. At first, mild mononuclear cell infiltration with loci of inflammatory cells in the retina was observed. Later, infiltration of photoreceptor cell layer, outer nuclear layer, and inner layer of the retina was characteristic. The cellular responses determined by in vitro lymphocyte proliferation assay indicated strong proliferative activity against immunizing peptide as early as 8 days after injection, with a peak of proliferative activity on days 15- 16. In studies to determine the importance of amino acid residues in induction of experimental autoimmune uveitis, sequence SATTQKAEKEVT (240- 251) has been found to be very immunopotent and to contain the uveitogenic site.

AB - Rhodopsin, a membrane protein of red photoreceptor cells, induces experimental autoimmune uveitis in Lewis rats. Synthetic peptides have been used to define pathogenic determinants for rhodopsin. Peptide 230-252 (loop V-VI) was found to contain a major uveitogenic site. Kinetics of the response to the peptide 230-252 was studied. Rats were given a single dose of the synthetic peptide 230-252 (VKEAAAQQQESATTQKAEKEVTR) mixed in complete Freund's adjuvant. Eyes, blood, and splenic lymphocytes were collected at different postinjection times. Histologically confirmed uveitis occurred 14 days after injection, and active inflammation was present for the next 10 days. At first, mild mononuclear cell infiltration with loci of inflammatory cells in the retina was observed. Later, infiltration of photoreceptor cell layer, outer nuclear layer, and inner layer of the retina was characteristic. The cellular responses determined by in vitro lymphocyte proliferation assay indicated strong proliferative activity against immunizing peptide as early as 8 days after injection, with a peak of proliferative activity on days 15- 16. In studies to determine the importance of amino acid residues in induction of experimental autoimmune uveitis, sequence SATTQKAEKEVT (240- 251) has been found to be very immunopotent and to contain the uveitogenic site.

UR - http://www.scopus.com/inward/record.url?scp=0028632771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028632771&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028632771

VL - 6

SP - 44

EP - 46

JO - Regional Immunology

JF - Regional Immunology

SN - 0896-0623

IS - 1-2

ER -